Parkinson's disease trials recruiting in Michigan

All Parkinson's disease trials nationally

Cities in Michigan

Recruiting trials in Michigan

• A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
  NCT06565195 · Phase: Phase 1 · Ages: 30 Years to 80 Years · Sex: All (male and female) · Michigan: Farmington Hills
• A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
  NCT06680830 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Farmington Hills
• A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
  NCT07543861 · Phase: Phase 1 · Ages: 50 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
  NCT06285643 · Phase: Phase 2 · Ages: 45 Years to 75 Years · Sex: All (male and female) · Michigan: East Lansing, Farmington Hills
• A Study of Buntanetap in Participants With PD
  NCT07284784 · Phase: Phase 2, Phase 3 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Michigan: Farmington Hills
• A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
  NCT06765668 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Farmington Hills
• A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
  NCT06809400 · Phase: Phase 1 · Ages: 30 Years to 85 Years · Sex: All (male and female) · Michigan: Farmington Hills
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
  NCT06976268 · Phase: Phase 2, Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Farmington Hills
• A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
  NCT07432958 · Phase: Phase 2 · Ages: 30 Years to 80 Years · Sex: All (male and female) · Michigan: Ann Arbor, Farmington Hills
• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
  NCT07174310 · Phase: Phase 3 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Michigan: Farmington Hills
• A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
  NCT07804615 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Michigan: Farmington Hills
• A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
  NCT06944522 · Phase: Phase 3 · Ages: 45 Years to 75 Years · Sex: All (male and female) · Michigan: Ann Arbor, Farmington Hills
• A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
  NCT07330258 · Phase: Not specified · Ages: 45 Years to 75 Years · Sex: All (male and female) · Michigan: Ann Arbor
• Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
  NCT07005180 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Farmington Hills
• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
  NCT04477785 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Parkinson's Foundation PD GENEration Genetic Registry
  NCT04994015 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
  NCT07154511 · Phase: Phase 1, Phase 2 · Ages: 45 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
  NCT04373317 · Phase: Phase 4 · Ages: 40 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
  NCT07422675 · Phase: Phase 1 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Michigan: Farmington Hills
• Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements
  NCT07599696 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · Michigan: East Lansing
• Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation
  NCT07642908 · Phase: Not specified · Ages: 45 Years and older · Sex: All (male and female) · Michigan: Ann Arbor